FDA Investigator R Edwadebey Deberry
R Edwadebey Deberry has conducted inspections on 6 sites in 1 countries as of 09 Feb 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
6
Last Inspection Date:
09 Feb 2024
Investigator Role:
FDA Investigation Participant
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with R Edwadebey Deberry:
Anastasia M Shields,
Bonita S Chester,
Burnell M Henry,
CDR Thomas R Berry, PPh,
Cherry R Valerio,
Christopher B May,
Christopher J Adams,
Christopher S Keating,
Claudette D Brooks,
Cynthia Jim, CSO,
Demario L Walls,
Devaughn Edwards,
Dorothy P Kramer,
Edward Deberry,
Eileen J Bannerman,
Eliezar Ramos,
Fabian Nchaparro Rodriguez,
Gabriel R Mclemore,
Gamal A Norton,
Jacqueline Mdiaz Albertini,
Jared P Stevens,
Jason F Chancey,
Jennifer L Bridgewater,
Julie D Bringger,
Larry K Hampton,
Lesley K Satterwhite,
Libia M Lugo,
Lillie D Witcher,
Marc A Alston,
Melanie M Walker,
Mihaly S Ligmond,
Nicole A Lloyd,
Paul A Bonneau,
Penny H Mccarver,
Prabhu P Raju,
Rachael L Cook,
Rebecca Rodriguez,
Robert C Coleman,
Robert D Tollefsen,
Scott T Ballard,
Seneca D Toms,
Sonya M Edmonds,
Stephen D Brown,
Steven M Weinman,
Susan T Hadman,
Tammara A Newberry,
Tammara A Stephens,
Veronica Fuentes, MS,
Viviana Matta
R Edwadebey Deberry's Documents
Publish Date | Document Type | Title |
---|---|---|
September, 2008 | FDA 483 | King Bio Inc - Form 483, 2008-09-25 |
September, 2007 | EIR | Baxter Healthcare Corporation - EIR, 2007-09-19 |
September, 2008 | EIR | Greer Laboratories, Inc. - EIR, 2008-09-15 |
September, 2006 | EIR | Greer Laboratories, Inc. - EIR, 2006-09-18 |
September, 2012 | EIR | Nypro Inc. - EIR, 2012-09-12 |
September, 2009 | EIR | Nypro Inc. - EIR, 2009-09-09 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more